Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,461 to 1,480 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AZD5438-PROTAC: A selective CDK2 degrader that protects against cisplatin- and noise-induced hearing loss. | Eur J Med Chem | 2021 | 34560429 | PubTator, text mining | PubMed |
| Prognostic and predictive biomarker developments in multiple myeloma. | J Hematol Oncol | 2021 | 34556161 | PubTator, text mining | PubMed |
| Cereblon: promise and challenges for combating human diseases. | Pflugers Arch | 2021 | 34553266 | PubTator, text mining | PubMed |
| Clinical Trials Assessing Hypomethylating Agents Combined with Other Therapies: Causes for Failure and Potential Solutions. | Clin Cancer Res | 2021 | 34551907 | PubTator, text mining | PubMed |
| Discovery of a Novel BCL-XL PROTAC Degrader with Enhanced BCL-2 Inhibition. | J Med Chem | 2021 | 34533954 | PubTator, text mining | PubMed |
| Pyrotinib combined with thalidomide in advanced non-small-cell lung cancer patients harboring HER2 exon 20 insertions (PRIDE): protocol of an open-label, single-arm phase II trial. | BMC Cancer | 2021 | 34530760 | PubTator, text mining | PubMed |
| An Overview of Lenalidomide in Combination with Rituximab for the Treatment of Adult Patients with Follicular Lymphoma: The Evidence to Date. | Drug Des Devel Ther | 2021 | 34522085 | PubTator, text mining | PubMed |
| Harnessing the E3 Ligase KEAP1 for Targeted Protein Degradation. | J Am Chem Soc | 2021 | 34520194 | PubTator, text mining | PubMed |
| Meaningful words in rectal MRI synoptic reports: How "polypoid" may be prognostic. | Clin Imaging | 2021 | 34517303 | PubTator, text mining | PubMed |
| Discovery, development and application of drugs targeting BCL-2 pro-survival proteins in cancer. | Biochem Soc Trans | 2021 | 34515749 | PubTator, text mining | PubMed |
| Review of Myeloma Therapies and Their Potential for Oral and Maxillofacial Side Effects. | Cancers (Basel) | 2021 | 34503289 | PubTator, text mining | PubMed |
| miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma. | Cancers (Basel) | 2021 | 34503175 | PubTator, text mining | PubMed |
| Choosing the Right Therapy for Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in Consideration of Patient-, Disease- and Treatment-Related Factors. | Cancers (Basel) | 2021 | 34503130 | PubTator, text mining | PubMed |
| The Ubiquitin System: An Emerging Therapeutic Target for Lung Cancer. | Int J Mol Sci | 2021 | 34502538 | PubTator, text mining | PubMed |
| Targeting KRAS in pancreatic cancer: new drugs on the horizon. | Cancer Metastasis Rev | 2021 | 34499267 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| Shigella ubiquitin ligase IpaH7.8 targets gasdermin D for degradation to prevent pyroptosis and enable infection. | Cell Host Microbe | 2021 | 34492225 | PubTator, text mining | PubMed |
| The E3 ubiquitin ligase component, Cereblon, is an evolutionarily conserved regulator of Wnt signaling. | Nat Commun | 2021 | 34489457 | PubTator, text mining | PubMed |
| Protein degradation technology: a strategic paradigm shift in drug discovery. | J Hematol Oncol | 2021 | 34488823 | PubTator, text mining | PubMed |
| Regulation of Ferroptosis Pathway by Ubiquitination. | Front Cell Dev Biol | 2021 | 34485285 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=74